AC

Asymmetry Capital Management, L.P.

Sector-focusedQuality / disciplined sizingLong-term holder

Total reported value

$188.4M

Reporting period: 2021-12-31 · Number of holdings: 24

Asymmetry Capital Management, L.P. disclosed 24 holdings in its latest 13F filing for the period ending 2021-12-31, with total reported value of $188.4M and a quarterly turnover rate of 0.0%.

Personality snowflake

Concentration
21.55
Portfolio Stability
0
Momentum/Contrarian
50
Sector conviction
100
Diversification
48
Sizing Uniformity
94.47

Recent moves

No holding changes this quarter

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1BMRNBiomarin Pharmaceutical INCStock-Healthcare8.34%——
2✓ Horizon Therapeutics PLCStock-Other7.87%—+451.57%
3UNHUnitedhealth Group INCStock-Healthcare7.16%——
4ABBVAbbvie INCStock-Healthcare6.79%——
5IQVIqvia Holdings INCStock-Healthcare6.64%——
6CNCCentene CORPStock-Healthcare6.48%——
7BLUBellus Health INCStock-Other5.47%—+19.40%
8CYTKCytokinetics INCStock-Healthcare5.44%—-8.65%
9JNJJohnson & JohnsonStock-Healthcare5.06%——
10NTRANatera INCStock-Healthcare5.04%——
11AM6Amicus Therapeutics INCStock-Other4.39%—+9.59%
12ARGXArgenx Se - AdrStock-Healthcare3.88%——
13KURAKura Oncology INCStock-Other3.73%—+158.49%
14APLSUSDApellis Pharmaceuticals INCStock-Other3.50%——
15MRTXEURMirati Therapeutics INCStock-Other3.42%—+4.49%
16OPHTEURIveric Bio INCStock-Other3.34%—+5.79%
17QTRXQuanterix CORPStock-Other3.22%—-11.57%
182662247DIteos Therapeutics INCStock-Other2.59%—+82.86%
19✓ DICE Therapeutics IncStock-Other2.49%—-32.69%
20✓ Avadel Pharmaceuticals PLCStock-Other1.58%—-22.18%
21ACRSAclaris Therapeutics INCStock-Other1.53%—-17.88%
22PMVPPmv Pharmaceuticals INCStock-Other1.20%—-3.17%
23RGLSUSDRegulus Therapeutics INCStock-Other0.46%—+94.87%
24✓ Bcls Acquisition CORPStock-Other0.37%—-2.64%

Holding changes this quarter

Position changes disclosed by Asymmetry Capital Management, L.P. for the quarter ending 2021-12-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction

FAQ

What is Asymmetry Capital Management, L.P. and what type of investor is it?
Asymmetry Capital Management, L.P. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2021-12-31), the firm manages a tracked equity portfolio valued at approximately $188.4M, spread across 24 disclosed positions.
What are Asymmetry Capital Management, L.P.'s largest equity positions?
Based on the latest 13F filing, Asymmetry Capital Management, L.P.'s top holdings by market value are: 1. Biomarin Pharmaceutical INC (BMRN) — $15.7M (8.3%) 2. Horizon Therapeutics PLC — $14.8M (7.9%) 3. Unitedhealth Group INC (UNH) — $13.5M (7.2%) 4. Abbvie INC (ABBV) — $12.8M (6.8%) 5. Iqvia Holdings INC (IQV) — $12.5M (6.6%)
What changes did Asymmetry Capital Management, L.P. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Asymmetry Capital Management, L.P. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Asymmetry Capital Management, L.P. focus on?
Asymmetry Capital Management, L.P. is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%